Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Josefa Fernandez-Del-Palacio

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scientific Reports|February 17, 2021
The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MIMaria Carmen Asensio-Lopez, Yassine Sassi, Fernando Soler, et al.
Journal of Visualized Experiments : Jove|February 15, 2018
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical ModelAlejandro Giraldo, Jesús Talavera López, Maria Josefa Fernandez-Del-Palacio, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 14, 2018
Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarctionMaria Del Carmen Asensio-Lopez, Antonio Lax, Maria Josefa Fernandez Del Palacio, et al.
Molecular Therapy. Nucleic Acids|May 26, 2023
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axisAntonio Lax, Fernando Soler, Maria Josefa Fernandez Del Palacio, et al.
Scientific Reports|August 13, 2020
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes statusMaria Del Carmen Asensio Lopez, Antonio Lax, Alvaro Hernandez Vicente, et al.
Scientific Reports|October 10, 2020
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes statusMaria Del Carmen Asensio Lopez, Antonio Lax, Alvaro Hernandez Vicente, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scientific Reports|February 17, 2021
The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MIMaria Carmen Asensio-Lopez, Yassine Sassi, Fernando Soler, et al.
Journal of Visualized Experiments : Jove|February 15, 2018
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical ModelAlejandro Giraldo, Jesús Talavera López, Maria Josefa Fernandez-Del-Palacio, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 14, 2018
Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarctionMaria Del Carmen Asensio-Lopez, Antonio Lax, Maria Josefa Fernandez Del Palacio, et al.
Molecular Therapy. Nucleic Acids|May 26, 2023
Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axisAntonio Lax, Fernando Soler, Maria Josefa Fernandez Del Palacio, et al.
Scientific Reports|August 13, 2020
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes statusMaria Del Carmen Asensio Lopez, Antonio Lax, Alvaro Hernandez Vicente, et al.
Scientific Reports|October 10, 2020
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes statusMaria Del Carmen Asensio Lopez, Antonio Lax, Alvaro Hernandez Vicente, et al.
Pageof 1